AirNexis

New Brand and Website for Cutting Edge COPD Treatment

AirNexis Therapeutics launches with a new brand and website from KBD

We’re thrilled to share a project we’ve had a lot of fun with: AirNexis Therapeutics came out of stealth this fall with a brand and launch website from KBD.

AirNexis is a clinical-stage biotech in Palo Alto, founded earlier this year with a $200 million Series A. The company is developing AN01, an inhaled treatment for COPD, and here’s the part that got us excited: it uses a proven scientific approach, delivered in a small handheld inhaler designed to fit right into a patient’s everyday life, instead of the bulky nebulizer that today’s options depend on. A genuinely patient-forward idea, and it became the heart of everything we designed.

The AirNexis team came to us with an ambitious timeline and a clear goal: stand up a credible public presence before a big industry moment in early September. So we got moving. In about six weeks, we delivered the AirNexis logo, a full brand identity, and a launch website, plus templates to carry the look into the company’s corporate materials and LinkedIn.

We started where we always do, with the story. Working closely with the AirNexis team, we dug into who they are and who they’re talking to, then built messaging that speaks to patients, caregivers, physicians, investors, and future hires, all without losing an ounce of the scientific credibility a company like this needs. From there, the design came to life: a warm, clean, welcoming identity that shows a company well on its way, with a website built to grow right alongside the science.

Watching it all come together this quickly was a real treat, and we couldn’t be prouder of what the AirNexis team pulled off. Congratulations to Maria, Michael, and the whole crew, we can’t wait to see where you take it.